Display options
Share it on

Basic Res Cardiol. 1982 Mar-Apr;77(2):188-96. doi: 10.1007/BF01908172.

Metabolic and haemodynamic responses to adrenaline in normal dogs.

Basic research in cardiology

A J Drake, K Herbaczynska-Cedro, L Ceremuzynski, W Czarnecki, M I Noble

PMID: 7092777 DOI: 10.1007/BF01908172

Abstract

The metabolic and haemodynamic effects of adrenaline were investigated in 6 intact anaesthetized dogs, which were subjected to an infusion of adrenaline. The dose given was similar to the endogenous production rate of adrenaline in experimental myocardial infarction. Adrenaline infusion (0.8, 1.17 ot 1.05 micrograms . kg-1 . min-1) over two hours led to a variable rise in blood level of this amine, regardless of the rate of infusion. Dogs with high blood adrenaline (over 3.5 ng . ml-1) exhibited haemodynamic deterioration, i.e. a rise in peripheral vascular resistance together with a fall in cardiac output and external cardiac work. Dogs with low blood adrenaline showed little change in peripheral vascular resistance, a rise in cardiac output and external cardiac work. The myocardial consumption of each of the substrates lactate, pyruvate, glucose and FFA was measured, and its equivalent oxygen consumption expressed as a percentage of the total myocardial oxygen consumption. No relationship was found between myocardial utilisation of individual substrates and the type of haemodynamic response. Thus in intact dogs exposed to adrenaline excess, similar to that found in acute myocardial infarction, the different types of haemodynamic response cannot be attributed to the type of substrate utilization by the myocardium, but to different rates of clearance of adrenaline. Low clearance rates lead to high blood adrenaline levels and an unfavourable response of the cardiovascular system.

References

  1. J Biol Chem. 1960 Sep;235:2595-9 - PubMed
  2. Am J Cardiol. 1978 Sep;42(3):363-71 - PubMed
  3. J Physiol. 1979 Feb;287:149-61 - PubMed
  4. Cardiovasc Res. 1970 Apr;4(2):168-75 - PubMed
  5. J Appl Physiol. 1972 Jun;32(6):847-58 - PubMed
  6. Am J Cardiol. 1967 Nov;20(5):605-17 - PubMed
  7. Circ Res. 1964 Apr;14:283-93 - PubMed
  8. Cardiovasc Res. 1978 Mar;12(3):179-89 - PubMed
  9. Lancet. 1974 Feb 23;1(7852):284-8 - PubMed
  10. Cardiology. 1973;58(4):220-8 - PubMed
  11. Acta Physiol Scand Suppl. 1955;33(118):45-56 - PubMed
  12. Eur J Clin Invest. 1970 Aug;1(2):77-83 - PubMed
  13. Circ Res. 1969 Nov;25(5):581-96 - PubMed
  14. Am Heart J. 1968 Sep;76(3):345-52 - PubMed
  15. Circ Res. 1980 Sep;47(3):338-45 - PubMed
  16. Cardiovasc Res. 1980 Feb;14(2):65-72 - PubMed
  17. Metabolism. 1963 Oct;12:936-40 - PubMed
  18. Circulation. 1969 Oct;40(4):473-81 - PubMed
  19. Eur J Clin Invest. 1980 Oct;10(5):401-6 - PubMed
  20. Cardiovasc Res. 1979 Apr;13(4):183-98 - PubMed

Substances

MeSH terms

Publication Types